Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Medtronic
Federal Trade Commission
UBS
Accenture
Boehringer Ingelheim
Deloitte
QuintilesIMS
Queensland Health
Harvard Business School

Generated: January 21, 2018

DrugPatentWatch Database Preview

TORA Drug Profile

« Back to Dashboard

Which patents cover Tora, and what generic alternatives are available?

Tora is a drug marketed by Solvay and Roche Palo and is included in three NDAs.

The generic ingredient in TORA is ketorolac tromethamine. There are eighteen drug master file entries for this compound. Fifty-four suppliers are listed for this compound. Additional details are available on the ketorolac tromethamine profile page.
Drug patent expirations by year for TORA
Medical Subject Heading (MeSH) Categories for TORA

US Patents and Regulatory Information for TORA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Solvay TORA phentermine hydrochloride TABLET;ORAL 084035-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Roche Palo TORADOL ketorolac tromethamine TABLET;ORAL 019645-001 Dec 20, 1991 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Roche Palo TORADOL ketorolac tromethamine INJECTABLE;INJECTION 019698-001 Nov 30, 1989 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Roche Palo TORADOL ketorolac tromethamine INJECTABLE;INJECTION 019698-002 Nov 30, 1989 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Boehringer Ingelheim
US Department of Justice
Baxter
Express Scripts
McKinsey
Accenture
Fish and Richardson
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot